NCT00509496 Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes Status TERMINATED Phase PHASE2
NCT00509288 Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes Status COMPLETED Phase PHASE2
NCT00506311 Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients Status COMPLETED Phase NA
NCT00495066 Compassionate Use Trial for Unresectable Melanoma With Ipilimumab Status NO_LONGER_AVAILABLE Phase N/A
NCT00492297 A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00482105 Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells Status TERMINATED Phase NA
NCT00477906 M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma Status UNKNOWN Phase PHASE3
NCT00466687 Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00463892 High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes Status COMPLETED Phase PHASE2
NCT00457418 High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2) Status COMPLETED Phase PHASE1
NCT00441662 Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema Status COMPLETED Phase NA
NCT00434252 A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00434057 Evaluation of Pigmented Skin Lesions With MelaFind(R) System Status COMPLETED Phase PHASE3